These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 16078102

  • 1. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
    Zhu X, Lu C, Xiao B, Qiao J, Sun Y.
    J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
    [Abstract] [Full Text] [Related]

  • 2. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
    Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM.
    J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
    [Abstract] [Full Text] [Related]

  • 3. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [Abstract] [Full Text] [Related]

  • 4. Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment.
    Pellegatta S, Poliani PL, Stucchi E, Corno D, Colombo CA, Orzan F, Ravanini M, Finocchiaro G.
    Neuro Oncol; 2010 Apr; 12(4):377-88. PubMed ID: 20308315
    [Abstract] [Full Text] [Related]

  • 5. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H, Yang B, Guan F, Li J, Shan H, Song L, Hu X, Liang S, Du Y, Jiang C.
    Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
    [Abstract] [Full Text] [Related]

  • 6. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J, Chen M, Peng ML, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [Abstract] [Full Text] [Related]

  • 7. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009 Mar; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 8. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
    Xiao ZY, Chen XJ, Yang Y, Xu RX.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug 18; 47(4):661-6. PubMed ID: 26284406
    [Abstract] [Full Text] [Related]

  • 9. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.
    Yamanaka R, Honma J, Tsuchiya N, Yajima N, Kobayashi T, Tanaka R.
    J Neurooncol; 2005 Apr 18; 72(2):107-13. PubMed ID: 15925989
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
    Yamanaka R, Zullo SA, Ramsey J, Yajima N, Tsuchiya N, Tanaka R, Blaese M, Xanthopoulos KG.
    J Neurosurg; 2002 Sep 18; 97(3):611-8. PubMed ID: 12296646
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cytotoxic activity of ex-vivo generated IFNα-induced monocyte-derived dendritic cells in brain glioma patients.
    Tyrinova TV, Leplina OY, Mishinov SV, Tikhonova MA, Shevela EY, Stupak VV, Pendyurin IV, Shilov AG, Alyamkina EA, Rubtsova NV, Bogachev SS, Ostanin AA, Chernykh ER.
    Cell Immunol; 2013 Sep 18; 284(1-2):146-53. PubMed ID: 23973877
    [Abstract] [Full Text] [Related]

  • 15. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
    Grauer OM, Sutmuller RP, van Maren W, Jacobs JF, Bennink E, Toonen LW, Nierkens S, Adema GJ.
    Int J Cancer; 2008 Apr 15; 122(8):1794-802. PubMed ID: 18076066
    [Abstract] [Full Text] [Related]

  • 16. [Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas].
    Yu JB, Feng ZX, Zhan RY.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Nov 15; 36(6):592-7. PubMed ID: 18067234
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of antitumor activity by combination of tumor lysate-pulsed dendritic cells and celecoxib in a rat glioma model.
    Zhang H, Tian M, Xiu C, Wang Y, Tang G.
    Oncol Res; 2013 Nov 15; 20(10):447-55. PubMed ID: 24308155
    [Abstract] [Full Text] [Related]

  • 18. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 15; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.